Interaction between α-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease

NeuroMolecular Medicine

Volumn 11, Issue 4, 2009, Pages 239-251

  Bisaglia, Marco ^a   Tessari, Isabella ^a   Mammi, Stefano ^a   Bubacco, Luigi ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Alpha synuclein; Copper; Fibrils; Metals; Neurodegeneration

Indexed keywords

ALPHA SYNUCLEIN; COPPER; IRON; METAL ION;

BINDING SITE; CHEMICAL MODIFICATION; ENVIRONMENT; IN VITRO STUDY; MEDICAL LITERATURE; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; REVIEW;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; HUMANS; LEWY BODIES; METALS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PARKINSON DISEASE; RATS;

EID: 72949084639     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8082-1     Document Type: Review

References (98)

1. A Abeliovich Y Schmitz I Farinas D Choi-Lundberg WH Ho PE Castillo N Shinsky JM Verdugo M Armanini A Ryan M Hynes H Phillips D Sulzer A Rosenthal 2000 Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 239 252 10.1016/S0896-6273(00)80886-7 10707987
2. D Berg MB Youdim P Riederer 2004 Redox imbalance Cell and Tissue Research 318 201 213 10.1007/s00441-004-0976-5 15365815 (Pubitemid 39362641)
3. CW Bertoncini YS Jung CO Fernandez W Hoyer C Griesinger TM Jovin M Zweckstetter 2005 Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein Proceedings of the National Academy of Sciences of the United States of America 102 1430 1435 10.1073/pnas.0407146102 15671169 (Pubitemid 40209187)
4. Bharathi, & Rao, K. S. (2007). Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease. Biochemical and Biophysical Research Communications, 359, 115-120.
5. A Binolfi GR Lamberto R Duran L Quintanar CW Bertoncini JM Souza C Cervenansky M Zweckstetter C Griesinger CO Fernandez 2008 Site-specific interactions of Cu(II) with alpha and beta-synuclein: Bridging the molecular gap between metal binding and aggregation Journal of the American Chemical Society 130 11801 11812 10.1021/ja803494v 18693689
6. A Binolfi RM Rasia CW Bertoncini M Ceolin M Zweckstetter C Griesinger TM Jovin CO Fernandez 2006 Interaction of alpha-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity and fibrillation enhancement Journal of the American Chemical Society 128 9893 9901 10.1021/ja0618649 16866548 (Pubitemid 44147975)
7. M Bisaglia S Mammi L Bubacco 2008 Structural insights on physiological functions and pathological effects of {alpha}-synuclein FASEB Journal 23 329 340 10.1096/fj.08-119784 18948383
8. M Bisaglia E Schievano A Caporale E Peggion S Mammi 2006 The 11-mer repeats of human alpha-synuclein in vesicle interactions and lipid composition discrimination: A cooperative role Biopolymers 84 310 316 10.1002/bip.20440 16411187
9. M Bisaglia I Tessari L Pinato M Bellanda S Giraudo M Fasano E Bergantino L Bubacco S Mammi 2005 A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles Biochemistry 44 329 339 10.1021/bi048448q 15628875 (Pubitemid 40095735)
10. AM Bodles DJ Guthrie B Greer GB Irvine 2001 Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity Journal of Neurochemistry 78 384 395 10.1046/j.1471-4159.2001.00408.x 11461974 (Pubitemid 32664420)
11. M Bortolus F Tombolato I Tessari M Bisaglia S Mammi L Bubacco A Ferrarini AL Maniero 2008 Broken helix in vesicle and micelle-bound alpha-synuclein: Insights from site-directed spin labeling-EPR experiments and MD simulations Journal of the American Chemical Society 130 6690 6691 10.1021/ja8010429 18457394 (Pubitemid 351748389)
12. DR Brown K Qin JW Herms A Madlung J Manson R Strome PE Fraser T Kruck A von Bohlen W Schulz-Schaeffer A Giese D Westaway H Kretzschmar 1997 The cellular prion protein binds copper in vivo Nature 390 684 687 10.1038/37733 9414160 (Pubitemid 28016346)
13. DE Cabin K Shimazu D Murphy NB Cole W Gottschalk KL McIlwain B Orrison A Chen CE Ellis R Paylor B Lu RL Nussbaum 2002 Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein Journal of Neuroscience 22 8797 8807 12388586
14. MC Chartier-Harlin J Kachergus C Roumier V Mouroux X Douay S Lincoln C Levecque L Larvor J Andrieux M Hulihan N Waucquier L Defebvre P Amouyel M Farrer A Destee 2004 Alpha-synuclein locus duplication as a cause of familial Parkinson's disease Lancet 364 1167 1169 10.1016/S0140-6736(04)17103-1 15451224 (Pubitemid 39296604)
15. M Chen M Margittai J Chen R Langen 2007 Investigation of alpha-synuclein fibril structure by site-directed spin labeling Journal of Biological Chemistry 282 24970 24979 10.1074/jbc.M700368200 17573347 (Pubitemid 47347515)
16. SJ Chinta JK Andersen 2008 Redox imbalance in Parkinson's disease Biochimica et Biophysica Acta 1780 1362 1367 18358848
17. NB Cole DD Murphy J Lebowitz L Di Noto RL Levine RL Nussbaum 2005 Metal-catalyzed oxidation of alpha-synuclein: Helping to define the relationship between oligomers, protofibrils, and filaments Journal of Biological Chemistry 280 9678 9690 10.1074/jbc.M409946200 15615715 (Pubitemid 40409666)
18. KA Conway SJ Lee JC Rochet TT Ding RE Williamson PT Lansbury Jr 2000 Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy Proceedings of the National Academy of Sciences of the United States of America 97 571 576 10.1073/pnas.97.2.571 10639120 (Pubitemid 30070350)
19. MR Cookson 2009 Alpha-synuclein and neuronal cell death Molecular Neurodegeneration 4 9 10.1186/1750-1326-4-9 19193223
20. WS Davidson A Jonas DF Clayton JM George 1998 Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes Journal of Biological Chemistry 273 9443 9449 10.1074/jbc.273.16.9443 9545270 (Pubitemid 28183026)
21. MM Dedmon K Lindorff-Larsen J Christodoulou M Vendruscolo CM Dobson 2005 Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations Journal of the American Chemical Society 127 476 477 10.1021/ja044834j 15643843 (Pubitemid 40174345)
22. A Der-Sarkissian CC Jao J Chen R Langen 2003 Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling Journal of Biological Chemistry 278 37530 37535 10.1074/jbc.M305266200 12815044 (Pubitemid 37175274)
23. DT Dexter A Carayon F Javoy-Agid Y Agid FR Wells SE Daniel AJ Lees P Jenner CD Marsden 1991 Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia Brain 114 Pt 4 1953 1975 10.1093/brain/114.4.1953 1832073
24. DT Dexter FR Wells AJ Lees F Agid Y Agid P Jenner CD Marsden 1989 Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease Journal of Neurochemistry 52 1830 1836 10.1111/j.1471-4159.1989.tb07264.x 2723638 (Pubitemid 19140770)
25. TT Ding SJ Lee JC Rochet PT Lansbury Jr 2002 Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes Biochemistry 41 10209 10217 10.1021/bi020139h 12162735 (Pubitemid 34856445)
26. ER Dorsey R Constantinescu JP Thompson KM Biglan RG Holloway K Kieburtz FJ Marshall BM Ravina G Schifitto A Siderowf CM Tanner 2007 Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Neurology 68 384 386 10.1212/01.wnl.0000247740.47667.03 17082464 (Pubitemid 46184217)
27. SC Drew SL Leong CL Pham DJ Tew CL Masters LA Miles R Cappai KJ Barnham 2008 Cu2+ binding modes of recombinant alpha-synuclein-insights from EPR spectroscopy Journal of the American Chemical Society 130 7766 7773 10.1021/ja800708x 18494470 (Pubitemid 351842140)
28. D Eliezer E Kutluay R Bussell Jr G Browne 2001 Conformational properties of alpha-synuclein in its free and lipid-associated states Journal of Molecular Biology 307 1061 1073 10.1006/jmbi.2001.4538 11286556 (Pubitemid 33029953)
29. AL Fink 2006 The aggregation and fibrillation of alpha-synuclein Accounts of Chemical Research 39 628 634 10.1021/ar050073t 16981679
30. TM Fountaine R Wade-Martins 2007 RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport Journal of Neuroscience Research 85 351 363 10.1002/jnr.21125 17131421 (Pubitemid 46219303)
31. AL Friedlich RE Tanzi JT Rogers 2007 The 5-untranslated region of Parkinson's disease alpha-synuclein messenger RNA contains a predicted iron responsive element Molecular Psychiatry 12 222 223 10.1038/sj.mp.4001937 17325711 (Pubitemid 46328508)
32. H Fujiwara M Hasegawa N Dohmae A Kawashima E Masliah MS Goldberg J Shen K Takio T Iwatsubo 2002 Alpha-synuclein is phosphorylated in synucleinopathy lesions Nature Cell Biology 4 160 164 10.1038/ncb841 11813001 (Pubitemid 34993702)
33. BI Giasson JE Duda IV Murray Q Chen JM Souza HI Hurtig H Ischiropoulos JQ Trojanowski VM Lee 2000 Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 985 989 10.1126/science.290.5493.985 11062131 (Pubitemid 30813267)
34. BI Giasson IV Murray JQ Trojanowski VM Lee 2001 A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly Journal of Biological Chemistry 276 2380 2386 10.1074/jbc.M008919200 11060312
35. Y Glinka KF Tipton MB Youdim 1996 Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine Journal of Neurochemistry 66 2004 2010 8780029
36. N Golts H Snyder M Frasier C Theisler P Choi B Wolozin 2002 Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein Journal of Biological Chemistry 277 16116 16123 10.1074/jbc.M107866200 11850416 (Pubitemid 34967897)
37. H Heise W Hoyer S Becker OC Andronesi D Riedel M Baldus 2005 Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR Proceedings of the National Academy of Sciences of the United States of America 102 15871 15876 10.1073/pnas.0506109102 16247008 (Pubitemid 41552835)
38. L Hong JD Simon 2009 Binding of Cu(II) to human alpha-synucleins: Comparison of wild type and the point mutations associated with the familial Parkinson's disease Journal of Physical Chemistry B 113 9551 9561 10.1021/jp809773y
39. AJ Hughes SE Daniel Y Ben-Shlomo AJ Lees 2002 The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 125 861 870 10.1093/brain/awf080 11912118
40. KJ Inglis D Chereau EF Brigham SS Chiou S Schobel NL Frigon M Yu RJ Caccavello S Nelson R Motter S Wright D Chian P Santiago F Soriano C Ramos K Powell JM Goldstein M Babcock T Yednock F Bard GS Basi H Sham TJ Chilcote L McConlogue I Griswold-Prenner JP Anderson 2009 Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system Journal of Biological Chemistry 284 2598 2602 10.1074/jbc.C800206200 19004816
41. A Iwai E Masliah M Yoshimoto N Ge L Flanagan HA de Silva A Kittel T Saitoh 1995 The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system Neuron 14 467 475 10.1016/0896-6273(95)90302-X 7857654
42. M Kostka T Hogen KM Danzer J Levin M Habeck A Wirth R Wagner CG Glabe S Finger U Heinzelmann P Garidel W Duan CA Ross H Kretzschmar A Giese 2008 Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers Journal of Biological Chemistry 283 10992 11003 10.1074/jbc.M709634200 18258594
43. Kowalik-Jankowska, T., Rajewska, A., Jankowska, E., & Grzonka, Z. (2006a). Copper(II) binding by fragments of alpha-synuclein containing M1-D2- and -H50-residues: A combined potentiometric and spectroscopic study. Dalton Transactions, 5068-5076.
44. T Kowalik-Jankowska A Rajewska E Jankowska K Wisniewska Z Grzonka 2006 Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide Journal of Inorganic Biochemistry 100 1623 1631 10.1016/j.jinorgbio.2006.05.010 16839607 (Pubitemid 44332524)
45. DE Krantz D Peter Y Liu RH Edwards 1997 Phosphorylation of a vesicular monoamine transporter by casein kinase II Journal of Biological Chemistry 272 6752 6759 10.1074/jbc.272.10.6752 9045708 (Pubitemid 27118163)
46. R Kruger W Kuhn T Muller D Woitalla M Graeber S Kosel H Przuntek JT Epplen L Schols O Riess 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nature Genetics 18 106 108 10.1038/ng0298-106 9462735
47. BC Lai SA Marion K Teschke JK Tsui 2002 Occupational and environmental risk factors for Parkinson's disease Parkinsonism & Related Disorders 8 297 309 10.1016/S1353-8020(01)00054-2 (Pubitemid 34520454)
48. KE Larsen Y Schmitz MD Troyer E Mosharov P Dietrich AZ Quazi M Savalle V Nemani FA Chaudhry RH Edwards L Stefanis D Sulzer 2006 Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis Journal of Neuroscience 26 11915 11922 10.1523/JNEUROSCI.3821-06.2006 17108165 (Pubitemid 44772102)
49. HA Lashuel D Hartley BM Petre T Walz PT Lansbury Jr 2002 Neurodegenerative disease: Amyloid pores from pathogenic mutations Nature 418 291 10.1038/418291a 12124613
50. JC Lee HB Gray JR Winkler 2008 Copper(II) binding to alpha-synuclein, the Parkinson's protein Journal of the American Chemical Society 130 6898 6899 10.1021/ja711415b 18465859 (Pubitemid 351770110)
51. EN Lee SY Lee D Lee J Kim SR Paik 2003 Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2 Journal of Neurochemistry 84 1128 1142 10.1046/j.1471-4159.2003.01612.x 12603836 (Pubitemid 36330665)
52. FJ Lee F Liu ZB Pristupa HB Niznik 2001 Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB Journal 15 916 926 10.1096/fj.00-0334com 11292651 (Pubitemid 32290778)
53. S Lesage A Brice 2009 Parkinson's disease: from monogenic forms to genetic susceptibility factors Human Molecular Genetics 18 R48 R59 10.1093/hmg/ddp012 19297401
54. W Li N West E Colla O Pletnikova JC Troncoso L Marsh TM Dawson P Jakala T Hartmann DL Price MK Lee 2005 Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations Proceedings of the National Academy of Sciences of the United States of America 102 2162 2167 10.1073/pnas.0406976102 15684072 (Pubitemid 40262029)
55. LL Liu KJ Franz 2007 Phosphorylation-dependent metal binding by alpha-synuclein peptide fragments JBIC Journal of Biological Inorganic Chemistry 12 234 247 10.1007/s00775-006-0181-y (Pubitemid 46197947)
56. J Lotharius S Barg P Wiekop C Lundberg HK Raymon P Brundin 2002 Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line Journal of Biological Chemistry 277 38884 38894 10.1074/jbc.M205518200 12145295 (Pubitemid 35154753)
57. DD Murphy SM Rueter JQ Trojanowski VM Lee 2000 Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons Journal of Neuroscience 20 3214 3220 10777786
58. IV Murray BI Giasson SM Quinn V Koppaka PH Axelsen H Ischiropoulos JQ Trojanowski VM Lee 2003 Role of alpha-synuclein carboxy-terminus on fibril formation in vitro Biochemistry 42 8530 8540 10.1021/bi027363r 12859200 (Pubitemid 36875420)
59. S Nakajo S Shioda Y Nakai K Nakaya 1994 Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization Brain Research. Molecular Brain Research 27 81 86 10.1016/0169-328X(94)90187-2 7877458 (Pubitemid 24324092)
60. SR Paik HJ Shin JH Lee 2000 Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide Archives of Biochemistry and Biophysics 378 269 277 10.1006/abbi.2000.1822 10860544 (Pubitemid 30397627)
61. SR Paik HJ Shin JH Lee CS Chang J Kim 1999 Copper(II)-induced self-oligomerization of alpha-synuclein Biochemical Journal 340 Pt 3 821 828 10.1042/0264-6021:3400821 10359669 (Pubitemid 29312882)
62. HS Pall AC Williams DR Blake J Lunec JM Gutteridge M Hall A Taylor 1987 Raised cerebrospinal-fluid copper concentration in Parkinson's disease Lancet 2 238 241 10.1016/S0140-6736(87)90827-0 2886715
63. J Peng L Peng FF Stevenson SR Doctrow JK Andersen 2007 Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration Journal of Neuroscience 27 6914 6922 10.1523/JNEUROSCI.1569-07.2007 17596439 (Pubitemid 47015904)
64. RG Perez JC Waymire E Lin JJ Liu F Guo MJ Zigmond 2002 A role for alpha-synuclein in the regulation of dopamine biosynthesis Journal of Neuroscience 22 3090 3099 11943812
65. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 2045 2047 10.1126/science.276.5321.2045 9197268 (Pubitemid 27443610)
66. P Ponka C Beaumont DR Richardson 1998 Function and regulation of transferrin and ferritin Seminars in Hematology 35 35 54 9460808
67. AN Pronin AJ Morris A Surguchov JL Benovic 2000 Synucleins are a novel class of substrates for G protein-coupled receptor kinases Journal of Biological Chemistry 275 26515 26522 10.1074/jbc.M003542200 10852916 (Pubitemid 30676709)
68. RM Rasia CW Bertoncini D Marsh W Hoyer D Cherny M Zweckstetter C Griesinger TM Jovin CO Fernandez 2005 Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 102 4294 4299 10.1073/pnas.0407881102 15767574 (Pubitemid 40397105)
69. P Riederer E Sofic WD Rausch B Schmidt GP Reynolds K Jellinger MB Youdim 1989 Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains Journal of Neurochemistry 52 515 520 10.1111/j.1471-4159.1989.tb09150.x 2911028 (Pubitemid 19037617)
70. JC Rochet KA Conway PT Lansbury Jr 2000 Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein Biochemistry 39 10619 10626 10.1021/bi001315u 10978144 (Pubitemid 30682769)
71. CA Ross MA Poirier 2005 Opinion: What is the role of protein aggregation in neurodegeneration? Nature Reviews. Molecular Cell Biology 6 891 898 10.1038/nrm1742 16167052 (Pubitemid 41568738)
72. M Sandal F Valle I Tessari S Mammi E Bergantino F Musiani M Brucale L Bubacco B Samori 2008 Conformational equilibria in monomeric alpha-synuclein at the single-molecule level PLoS Biology 6 e6 10.1371/journal.pbio.0060006 18198943 (Pubitemid 351226050)
73. JP Segrest MK Jones H De Loof CG Brouillette YV Venkatachalapathi GM Anantharamaiah 1992 The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function Journal of Lipid Research 33 141 166 1569369
74. LC Serpell J Berriman R Jakes M Goedert RA Crowther 2000 Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation Proceedings of the National Academy of Sciences of the United States of America 97 4897 4902 10.1073/pnas.97.9.4897 10781096 (Pubitemid 30238654)
75. CW Shults 2006 Lewy bodies Proceedings of the National Academy of Sciences of the United States of America 103 1661 1668 10.1073/pnas.0509567103 16449387 (Pubitemid 43228751)
76. AB Singleton M Farrer J Johnson A Singleton S Hague J Kachergus M Hulihan T Peuralinna A Dutra R Nussbaum S Lincoln A Crawley M Hanson D Maraganore C Adler MR Cookson M Muenter M Baptista D Miller J Blancato J Hardy K Gwinn-Hardy 2003 Alpha-synuclein locus triplication causes Parkinson's disease Science 302 841 10.1126/science.1090278 14593171 (Pubitemid 37339619)
77. JM Souza BI Giasson Q Chen VM Lee H Ischiropoulos 2000 Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies Journal of Biological Chemistry 275 18344 18349 10.1074/jbc.M000206200 10747881 (Pubitemid 30414790)
78. MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert 1997 Alpha-synuclein in Lewy bodies Nature 388 839 840 10.1038/42166 9278044 (Pubitemid 27377048)
79. AH Stokes TG Hastings KE Vrana 1999 Cytotoxic and genotoxic potential of dopamine Journal of Neuroscience Research 55 659 665 10.1002/(SICI)1097- 4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C 10220107 (Pubitemid 29173480)
80. YH Sung C Rospigliosi D Eliezer 2006 NMR mapping of copper binding sites in alpha-synuclein Biochimica et Biophysica Acta 1764 5 12 16338184
81. R Tehranian SE Montoya AD Van Laar TG Hastings RG Perez 2006 Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells Journal of Neurochemistry 99 1188 1196 10.1111/j.1471-4159. 2006.04146.x 16981894 (Pubitemid 44655284)
82. TS Ulmer A Bax NB Cole RL Nussbaum 2005 Structure and dynamics of micelle-bound human alpha-synuclein Journal of Biological Chemistry 280 9595 9603 10.1074/jbc.M411805200 15615727 (Pubitemid 40409655)
83. VN Uversky 2003 A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders Journal of Biomolecular Structure and Dynamics 21 211 234 12956606
84. VN Uversky J Li AL Fink 2001 Evidence for a partially folded intermediate in alpha-synuclein fibril formation Journal of Biological Chemistry 276 10737 10744 10.1074/jbc.M010907200 11152691 (Pubitemid 38089246)
85. VN Uversky J Li AL Fink 2001 Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure Journal of Biological Chemistry 276 44284 44296 10.1074/jbc.M105343200 11553618
86. VN Uversky G Yamin LA Munishkina MA Karymov IS Millett S Doniach YL Lyubchenko AL Fink 2005 Effects of nitration on the structure and aggregation of alpha-synuclein Brain Research. Molecular Brain Research 134 84 102 10.1016/j.molbrainres.2004.11.014 15790533 (Pubitemid 40403641)
87. VN Uversky G Yamin PO Souillac J Goers CB Glaser AL Fink 2002 Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro FEBS Letters 517 239 244 10.1016/S0014-5793(02)02638-8 12062445 (Pubitemid 34327667)
88. M Vilar HT Chou T Luhrs SK Maji D Riek-Loher R Verel G Manning H Stahlberg R Riek 2008 The fold of alpha-synuclein fibrils Proceedings of the National Academy of Sciences of the United States of America 105 8637 8642 10.1073/pnas.0712179105 18550842 (Pubitemid 351987732)
89. MJ Volles PT Lansbury Jr 2002 Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism Biochemistry 41 4595 4602 10.1021/bi0121353 11926821 (Pubitemid 34275660)
90. PH Weinreb W Zhen AW Poon KA Conway PT Lansbury Jr 1996 NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded Biochemistry 35 13709 13715 10.1021/bi961799n 8901511 (Pubitemid 26363912)
91. C Wersinger D Prou P Vernier A Sidhu 2003 Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress FASEB Journal 17 2151 2153 12958153
92. DR Brown X Wang JA Wright 2009 Unique copper-induced oligomers mediate alpha-synuclein toxicity FASEB Journal 23 4069 4076 10.1096/fj.09-131367
93. G Yamin CB Glaser VN Uversky AL Fink 2003 Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein Journal of Biological Chemistry 278 27630 27635 10.1074/jbc.M303302200 12754258 (Pubitemid 36899949)
94. L Yavich H Tanila S Vepsalainen P Jakala 2004 Role of alpha-synuclein in presynaptic dopamine recruitment Journal of Neuroscience 24 11165 11170 10.1523/JNEUROSCI.2559-04.2004 15590933 (Pubitemid 40012976)
95. MB Youdim D Ben-Shachar P Riederer 1991 Iron in brain function and dysfunction with emphasis on Parkinson's disease European Neurology 31 Suppl 1 34 40 10.1159/000116719 1649757
96. WR Yu H Jiang J Wang JX Xie 2008 Copper (Cu2+) induces degeneration of dopaminergic neurons in the nigrostriatal system of rats Neuroscience Bulletin 24 73 78 10.1007/s12264-008-0073-y 18369385 (Pubitemid 351738281)
97. JJ Zarranz J Alegre JC Gomez-Esteban E Lezcano R Ros I Ampuero L Vidal J Hoenicka O Rodriguez B Atares V Llorens E Gomez Tortosa T del Ser DG Munoz JG de Yebenes 2004 The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Annals of Neurology 55 164 173 10.1002/ana.10795 14755719 (Pubitemid 38166992)
98. L Zecca A Stroppolo A Gatti D Tampellini M Toscani M Gallorini G Giaveri P Arosio P Santambrogio RG Fariello E Karatekin MH Kleinman N Turro O Hornykiewicz FA Zucca 2004 The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging Proceedings of the National Academy of Sciences of the United States of America 101 9843 9848 10.1073/pnas.0403495101 15210960 (Pubitemid 38869324)